Norwood Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$38.9K Sell
50
-20
-29% -$14.2K 0.06% 171
2023
Q4
$40.8K Hold
70
0.06% 158
2023
Q3
$37.6K Sell
70
-125
-64% -$64.4K 0.06% 160
2023
Q2
$91.4K Sell
195
-20
-9% -$8.39K 0.14% 110
2023
Q1
$73.8K Sell
215
-40
-16% -$13.5K 0.12% 114
2022
Q4
$93.3K Hold
255
0.15% 101
2022
Q3
$82K Hold
255
0.15% 102
2022
Q2
$83K Hold
255
0.14% 104
2022
Q1
$73K Hold
255
0.11% 112
2021
Q4
$70K Buy
+255
New +$64.6K 0.1% 116

Other funds holding LLY

Norwood Financial's LLY Position: Q1 2024 in Review

Norwood Financial reduced its Eli Lilly (LLY) stake by 29% in Q1 2024, selling an estimated $14.2K and leaving 50 shares worth $38.9K. The position accounts for 0.06% of the portfolio, ranked #171.

Norwood Financial first reported a position in LLY in Q4 2021 and has held it in 10 quarters since. The position peaked at $93.3K in Q4 2022. 3,461 funds tracked by Wall St. Rank hold LLY as of Q1 2024.

  • Norwood Financial held 50 shares of Eli Lilly worth $38.9K as of Q1 2024.
  • Norwood Financial sold 20 Eli Lilly shares in Q1 2024, an estimated $14.2K.
  • Eli Lilly made up 0.06% of Norwood Financial's portfolio in Q1 2024, its #171 holding.
  • Norwood Financial first reported a position in Eli Lilly in Q4 2021 and has held it in 10 quarters since.
  • Norwood Financial's Eli Lilly position peaked at $93.3K in Q4 2022.
  • 3,461 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2024.

Based on Norwood Financial's 13F filing for Q1 2024, filed 16 Apr 2024.